Adaptive Biotechnologies (ADPT) FCF Margin Growth (5y) (2023 - 2026)
Powered by 
Analysis
Adaptive Biotechnologies (ADPT) FCF Margin Growth (5y) (2023 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Natera | 49.39 Bn | 48.29 Bn | 486.15 Mn |
| 2 | Quest Diagnostics | 27.49 Bn | 26.86 Bn | 1.03 Bn |
| 3 | Labcorp Holdings | 26.51 Bn | 26.37 Bn | 1.11 Bn |
| 4 | Guardant Health | 23.17 Bn | 22.12 Bn | 219.03 Mn |
| 5 | Tempus AI | 12.59 Bn | 11.77 Bn | 274.25 Mn |
| 6 | Caris Life Sciences | 8.01 Bn | 7.22 Bn | 182.38 Mn |
| 7 | Sotera Health | 5.53 Bn | 5.17 Bn | 177.96 Mn |
| 8 | BillionToOne | 4.80 Bn | 4.25 Bn | 77.11 Mn |
| 9 | Adaptive Biotechnologies | 4.40 Bn | 4.05 Bn | 51.39 Mn |
| 10 | iRhythm Holdings | 3.68 Bn | 3.08 Bn | 163.21 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 14,329.00 |
| Mar 31, 2026 | 17,814.00 |
| Dec 31, 2025 | 16,502.00 |
| Sep 30, 2025 | 18,728.00 |
| Jun 30, 2025 | 13,663.00 |
| Mar 31, 2025 | 10,861.00 |
| Dec 31, 2024 | 9,416.00 |
| Sep 30, 2024 | 6,979.00 |
| Jun 30, 2024 | 3,495.00 |
| Mar 31, 2024 | -226,220.00 |
| Dec 31, 2023 | -1,568.00 |
| Sep 30, 2023 | -4,971.00 |